Literature DB >> 20142973

The moorfields safer surgery system.

Sumit Dhingra1, Peng T Khaw.   

Abstract

This review presents the 'Moorfields Safer Surgery System', which is designed to improve the consistency and outcomes of trabeculectomy surgery. Evidence-based recommendations are made for each step of the surgery. This system requires a minimum of equipment and can be easily implemented by most surgeons. The system is ultimately designed to preserve the vision in our patients by minimising complications while maintaining a desired intraocular pressure.

Entities:  

Keywords:  Glaucoma; surgery; trabeculectomy

Year:  2009        PMID: 20142973      PMCID: PMC2813606          DOI: 10.4103/0974-9233.56220

Source DB:  PubMed          Journal:  Middle East Afr J Ophthalmol        ISSN: 0974-9233


INTRODUCTION

The Moorfields Safer Surgery System is designed to improve surgical outcomes for our patients following trabeculectomy. Our fundamental observation that cystic blebs have restricted posterior flow with the so-called “ring of steel” was critical in the initial conception of this system. Over the years the system has evolved to include many other features based on evidence from basic science and clinical research. A comprehensive description of the system is available elsewhere;1 below is a less detailed summary of our recommendations.

SITE FOR SURGERY

The superior half of the globe is the safest site for the trabeculectomy due to the reduced incidence of inflammation, endophthalmitis, dysthesia and recurrent subconjunctival haemorrhages.2–4 The upper lid can also provide mechanical protection and covers the iridectomy, preventing diplopia. In cases where the only sites available are interpalpebral or inferior, we suggest that a tube drainage device should be preferred.

TRACTION SUTURE

We prefer a corneal traction suture (7/0 black silk suture on a semi-circular needle) to a superior rectus suture [Figure 1]. This removes the possibility of a superior-rectus haematoma with the added benefits of a superior vector force5 and a reduced risk of failure.6 When the suture is placed at the correct depth, the risk of either ocular penetration or alternatively “cheese-wiring” and loss of traction is minimised.
Figure 1

Corneal traction suture

Corneal traction suture

CONJUNCTIVAL INCISION

In the past we made a conjunctival incision deep in the fornix (limbus based conjunctival flap) to reduce the chance of a wound leakage. Although, with this incision, a diffuse bleb can be achieved, a limbal conjunctival incision (fornix based conjunctival flap) is a less technically difficult method to achieve posterior aqueous and a diffuse bleb.7–9 To minimise surgical trauma and wound leakage, a conjunctival incision of 5-10 mm is made at the limbus without any relieving incisions.

SCLERAL FLAP

We create a rectangular scleral flap by first cutting a horizontal incision parallel to the limbus, then dissecting a partial thickness scleral pocket (much like a phacoemulsification pocket) and finally cutting the two side incisions. By not completing the side incisions right up to the limbus, the aqueous is directed backwards over a wider area, encouraging greater posterior flow and a more diffuse bleb. The scleral flap must be large enough to provide resistance and be not too thin so as to risk dehiscence or “cheese-wiring” of the flap sutures. Any large aqueous veins at the potential site of the flap must be avoided.

CONJUNCTIVAL POCKET

A wide pocket for applying the antimetabolite sponges behind the flap and underneath the conjunctiva is made with Westcott scissors. When dissecting over the superior rectus, care must be taken to lift the conjunctiva and to cut attachments avoiding the tendon. Any intra-operative antimetabolites should be applied after constructing the scleral flap but before the eye is entered, so if there are any concerns, the antimetabolites can be withheld.

ANTIMETABOLITE TREATMENT DURATION

A large surface area is treated with antimetabolite to reduce the development of a ring of scar tissue. Based on our pharmacokinetic experiments, mitomycin C (MMC) is applied at a concentration of 0.2 or 0.5 mg/ml for three minutes, or alternatively 5-Fluorouracil (5-FU) 50 mg/ml may be used.1011 The antimetabolite must then be washed out thoroughly, with at least 20 ml of balanced salt solution.

SPONGES AND CONJUNCTIVAL CLAMP

We use approximately three circular medical grade polyvinyl alcohol sponges (which are usually used for LASIK as corneal shields) as they do not fragment.12 These are either cut in half or whole, and folded like a lens to pass comfortably into the conjunctival pocket without making contact with the edges, reducing the chances of postoperative wound leakage or dehiscence [Figure 2]. For the same reason, we also use a custom made clamp designed to hold back the conjunctiva (Khaw Small Conjunctival Clamp No.2-686; Duckworth and Kent Ltd.) to insert and remove the sponges.
Figure 2

Non-fragmenting, circular medical grade polyvinyl alcohol sponges cut in half

Non-fragmenting, circular medical grade polyvinyl alcohol sponges cut in half

PARACENTESIS AND INFUSION

A paracentesis allows improved control of the anterior chamber depth. If it is made obliquely and parallel to the limbus, it reduces the possibility of lens damage. Furthermore, if it is also sited inferiorly it may also be used post-operatively in the clinic. For enhanced pressure control, we use a continuous anterior segment infusion (Lewicky; Visitec Company, Sarasota, FL), which continuously maintains the pressure, with the flexibility to adjust it by changing the bottle height.

SCLEROSTOMY

Although a sclerostomy can be made manually with a blade and scissors, we favour a specially designed punch (Khaw Small Descement Membrane Punch No. 7-101; Duckworth and Kent Ltd). This allows superior anterior access (even if the sides of the sclerosotomy are not fully exposed) and permits the relatively straightforward construction of a small sclerostomy, slightly larger than the head of the punch (0.5 mm diameter). This size is functionally adequate, as well as having the benefit of reduced astigmatism and reduced anterior aqueous flow.13 A perpendicular, clean, non-shelved incision should be made precisely at the sclerolimbal junction. This will then appear at the anterior part of the trabecular meshwork reducing the chance of bleeding or damage to the ciliary body.

PERIPHERAL IRIDECTOMY

A peripheral iridectomy prevents iris incarceration in the sclerostomy, therefore relieving any element of pupillary block. By cutting it with scissors parallel to the limbus, a relatively small defect can be made, reducing the chances of glare and diplopia. As we use an infusion, gentle pressure on the back of the wound brings the iris into the wound, allowing the iridectomy to be cut without intraocular manipulation, which minimises trauma and the need for an assistant.

SCLERAL FLAP SUTURES

The function of the sutures is to secure the flap so that it acts as an aqueous flow restrictor. This may be particularly important when antimetabolites are used, or in an eye with angle closure. We usually pre-place, but do not tie, a couple of sutures while the eye is still firm. Once ready, we first tie the sutures at the posterior corner of the scleral flap (Alcon; 10/0 monofilament nylon suture). The need for further sutures is then assessed by the amount of aqueous flowing through the flap (by either having a continuous anterior chamber infusion or by manually inflating the eye). The advantage of an infusion is that the flow and final intra-ocular pressure can be set more accurately. The scleral flap sutures may need to be adjusted in the post-operative period to increase flow. This should be done cautiously as hypotony may result, even several months post-operatively. Sutures can be removed by laser suture-lysis, though there is a risk of suddenly lowering the pressure. Therefore, we prefer the safer releasable suture, or our adjustable suture technique.1415 The new type of adjustable suture allows precise post-operative control of the suture tension through the conjunctiva with a specially designed forceps which has smooth edges (Khaw Transconjunctival Adjustable Suture Control Forceps, No. 2-502; Duckworth and Kent Ltd.,) [Figure 3].
Figure 3

Transconjunctival adjustment of suture tension with specially designed forceps

Transconjunctival adjustment of suture tension with specially designed forceps

CONJUNCTIVAL CLOSURE

When suturing conjunctiva, it is essential to use a round-bodied (rather than a spatulated) needle as any conjunctival holes will close more spontaneously. Although there are many alternatives, we prefer a more comprehensive conjunctival closure with a continuous nylon suture and buried knots in shallow corneal grooves [Figure 4]. This technique has in effect eliminated central conjunctival retraction, leaks and suture discomfort in our patients.
Figure 4

Closure of the conjunctiva with buried knots in shallow corneal grooves

Closure of the conjunctiva with buried knots in shallow corneal grooves

CONCLUSIONS

The Moorfields Safer Surgery System has improved the surgical outcomes for our patients following trabeculectomy.7 We strongly believe that by following this evolving system, in combination with newer anti-scarring agents, it will be possible in the future to even further increase the efficacy and safety of glaucoma surgery. Video downloads of the Moorfields Safer Surgery System are available at: http://www.ucl.ac.uk/ioo/research/khawlibrary
  13 in total

Review 1.  Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy.

Authors:  P T Khaw
Journal:  J Glaucoma       Date:  2001-10       Impact factor: 2.503

2.  Safe trabeculectomy technique: long term outcome.

Authors:  I Stalmans; A Gillis; A-S Lafaut; T Zeyen
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Comparison of fornix- and limbus-based conjunctival flaps in mitomycin C trabeculectomy with laser suture lysis in Japanese glaucoma patients.

Authors:  Takeo Fukuchi; Jun Ueda; Kiyoshi Yaoeda; Kieko Suda; Masaaki Seki; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

4.  Sponge delivery variables and tissue levels of 5-fluorouracil.

Authors:  M R Wilkins; N L Occleston; A Kotecha; L Waters; P T Khaw
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

5.  Experimental flow studies in glaucoma drainage device development.

Authors: 
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

6.  Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152.

Authors:  Franz Grehn; Gábor Holló; Peng Khaw; Barry Overton; Rosamund Wilson; Roger Vogel; Zaid Smith
Journal:  Ophthalmology       Date:  2007-08-27       Impact factor: 12.079

7.  Fornix vs limbal-based trabeculectomy with mitomycin C.

Authors:  A Alwitry; V Patel; A W King
Journal:  Eye (Lond)       Date:  2005-06       Impact factor: 3.775

8.  Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery.

Authors:  Anthony P Wells; Catey Bunce; Peng T Khaw
Journal:  J Glaucoma       Date:  2004-10       Impact factor: 2.503

9.  Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil.

Authors:  B Wolner; J M Liebmann; J W Sassani; R Ritch; M Speaker; M Marmor
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

10.  Factors associated with success in first-time trabeculectomy for patients at low risk of failure with chronic open-angle glaucoma.

Authors:  Beth Edmunds; Catey V Bunce; John R Thompson; John F Salmon; Richard P Wormald
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

View more
  17 in total

1.  Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: retrospective review.

Authors:  Zeynep Aktas; Safak Korkmaz; Murat Hasanreisoglu; Merih Onol; Berati Hasanreisoglu
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma.

Authors:  Igor Leleu; Benjamin Penaud; Esther Blumen-Ohana; Thibault Rodallec; Raphaël Adam; Olivier Laplace; Jad Akesbi; Jean-Philippe Nordmann
Journal:  Eye (Lond)       Date:  2019-01-24       Impact factor: 3.775

3.  Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.

Authors:  S Cillino; F Di Pace; G Cillino; A Casuccio
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

4.  Is there a change in the quality of life comparing the micro-invasive glaucoma surgery (MIGS) and the filtration technique trabeculectomy in glaucoma patients?

Authors:  Milena Pahlitzsch; Matthias K J Klamann; Marie-Luise Pahlitzsch; Johannes Gonnermann; Necip Torun; Eckart Bertelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-15       Impact factor: 3.117

5.  Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.

Authors:  R R Khandelwal; D Raje; A Rathi; A Agashe; M Majumdar; R Khandelwal
Journal:  Eye (Lond)       Date:  2014-12-12       Impact factor: 3.775

Review 6.  Advanced glaucoma: management pearls.

Authors:  Girum W Gessesse; Karim F Damji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

Review 7.  Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.

Authors:  Emily Cabourne; Jonathan C K Clarke; Patricio G Schlottmann; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2015-11-06

8.  The Influence of Scleral Flap Thickness, Shape, and Sutures on Intraocular Pressure (IOP) and Aqueous Humor Flow Direction in a Trabeculectomy Model.

Authors:  Amir Samsudin; Ian Eames; Steve Brocchini; Peng Tee Khaw
Journal:  J Glaucoma       Date:  2016-07       Impact factor: 2.503

Review 9.  Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I).

Authors:  Jennifer C Fan Gaskin; Dan Q Nguyen; Ghee Soon Ang; Jeremy O'Connor; Jonathan G Crowston
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12

10.  Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.

Authors:  Salvatore Cillino; Alessandra Casuccio; Francesco Di Pace; Carlo Cagini; Lucia Lee Ferraro; Giovanni Cillino
Journal:  BMC Ophthalmol       Date:  2016-03-05       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.